Yahoo Finance1mon
MYGN Stock Might Gain From the New Recognition of RiskScore Study
RiskScore integrates a polygenic risk score (PRS) for all ancestries with the widely used Tyrer-Cuzick model. The study demonstrated that Myriad’s PRS is a more accurate predictor of breast ...
manilatimes1mon
Myriad Genetics' RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
RiskScore integrates a polygenic risk score (PRS) for all ancestries with the widely used Tyrer-Cuzick model. The study demonstrated that Myriad's PRS is a more accurate predictor of breast cancer ...
BioSpace1mon
Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
RiskScore integrates a polygenic risk score (PRS) for all ancestries with the widely used Tyrer-Cuzick model. The study demonstrated that Myriad’s PRS is a more accurate predictor of breast cancer ...
Nasdaq1mon
Myriad Genetics' MyRisk® Hereditary Cancer Test with RiskScore® Recognized as Top Advance in Genomic Medicine
Myriad's RiskScore shows double the predictive ability compared to Tyrer-Cuzick and emphasizes the company's commitment to health equity by providing multi-ancestry insights. This recognition is ...